
Please try another search
By Sam Boughedda
Agilon Health Inc (NYSE:AGL) shares dipped Monday after Citron Research released a short report on the stock.
Citron, which in January 2021, said they would stop releasing short reports following the GameStop (NYSE:GME) and AMC Entertainment (NYSE:AMC) buying frenzy, recently began publishing its short research once again.
It has now taken aim at Agilon Health, stating "the best days of Agilon are behind it" as the business model "unknowingly got torpedoed" by the U.S. Supreme Court without Wall Street noticing.
"Agilon's business model is to partner with primary care physicians (PCP) and generate profits shared from cutting costs and Medicare overpayments. While the company uses many bombastic phrases like reinventing healthcare, Agilon is one of many companies in the category of 'physicians' management services," said Citron.
In addition, Citron said Agilon does not own clinics or practices and does not have long-term contracts with payors.
"This unprofitable business is based on arrangements with physician groups to split additional profitability once uploaded on the Agilon platform. The majority of these yet unrealized profits are to be generated through the increase of medical margin," they added.
The firm also argues that Agilon "inflates its medical margin by including a line item titled 'other medical expenses.'"
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.